标题
Inflammation and prostate cancer: friends or foe?
作者
关键词
Prostate, Cancer, Immunity, Chemokines
出版物
INFLAMMATION RESEARCH
Volume 64, Issue 5, Pages 275-286
出版商
Springer Nature
发表日期
2015-03-19
DOI
10.1007/s00011-015-0812-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of the Current Prostate Cancer Staging System Based on Cancer-Specific Mortality in the Surveillance, Epidemiology, and End Results Database
- (2015) Monica E. Shukla et al. Clinical Genitourinary Cancer
- Intratumour Heterogeneity in Urologic Cancers: From Molecular Evidence to Clinical Implications
- (2015) Marco Gerlinger et al. EUROPEAN UROLOGY
- Genetic predisposition to prostate cancer: Update and future perspectives
- (2015) Francesca Demichelis et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1
- (2015) Arun Bhardwaj et al. Oncotarget
- Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells
- (2015) Pamela J. Maxwell et al. Oncotarget
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- Current early diagnostic biomarkers of prostate cancer
- (2014) Ying-Hao Sun et al. ASIAN JOURNAL OF ANDROLOGY
- CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells
- (2014) Yun-Hee Rhee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents
- (2014) Christopher K. Arnatt et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
- (2014) Stuart J Ellem et al. JOURNAL OF PATHOLOGY
- Intriguing data on inflammation and prostate cancer
- (2014) Linda Vignozzi et al. Nature Reviews Urology
- Mast cell phenotype in benign and malignant tumors of the prostate
- (2014) Tatiana Globa et al. POLISH JOURNAL OF PATHOLOGY
- Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
- (2014) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival
- (2014) Jaya Sharma et al. PROSTATE
- Tumor Microenvironment and Metabolism in Prostate Cancer
- (2014) Paola Chiarugi et al. SEMINARS IN ONCOLOGY
- CC Chemokine Ligand 18 and IGF-Binding Protein 6 as Potential Serum Biomarkers for Prostate Cancer
- (2014) Yong Xu et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer
- (2014) Cheng Peng et al. TUMOR BIOLOGY
- Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer
- (2014) Raju K. Mandal et al. TUMOR BIOLOGY
- Random biopsy: when, how many and where to take the cores?
- (2014) Vincenzo Scattoni et al. WORLD JOURNAL OF UROLOGY
- CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
- (2014) Igor Tsaur et al. Cancer Research and Treatment
- The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
- (2014) M. Lanciotti et al. Biomed Research International
- Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up
- (2014) Andreas Dimakakos et al. Biomed Research International
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- Androgen receptor, ccl2, and epithelial-mesenchymal transition
- (2014) Wen-Jye Lin et al. OncoImmunology
- Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
- (2014) Raju R Raval et al. Journal for ImmunoTherapy of Cancer
- Analysis of circulating regulatory T cells (CD4+CD25+CD127−) after cryosurgery in prostate cancer
- (2013) Tong-Guo Si et al. ASIAN JOURNAL OF ANDROLOGY
- CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration
- (2013) Tien-Huang Lin et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy
- (2013) Marianne Schmid et al. Biomarkers in Medicine
- Destructive impact of t-lymphocytes, NK and mast cells on basal cell layers: implications for tumor invasion
- (2013) Hongyan Yuan et al. BMC CANCER
- Clinical evaluation of systemic and local immune responses in cancer: time for integration
- (2013) Dmitriy W. Gutkin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee
- (2013) M. Ittmann et al. CANCER RESEARCH
- Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
- (2013) L.-Y. Fang et al. CANCER RESEARCH
- CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
- (2013) J. Xu et al. CANCER RESEARCH
- Anterograde Trafficking of CXCR4 and CCR2 Receptors in a Prostate Cancer Cell Line
- (2013) Kelsie Gillies et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression
- (2013) Nicole Salazar et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling
- (2013) Taku Kato et al. CYTOKINE
- Mast Cells as a Potential Prognostic Marker in Prostate Cancer
- (2013) Gianluigi Taverna et al. DISEASE MARKERS
- Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
- (2013) Kouji Izumi et al. EMBO Molecular Medicine
- Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents
- (2013) Christopher K. Arnatt et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Does the microenvironment influence the cell types of origin for prostate cancer?
- (2013) A. S. Goldstein et al. GENES & DEVELOPMENT
- Immune system: a double-edged sword in cancer
- (2013) Bodduluru Lakshmi Narendra et al. INFLAMMATION RESEARCH
- Current Status of Biomarkers for Prostate Cancer
- (2013) Vicki Velonas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone
- (2013) Peter Kirk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inflammation and prostate carcinogenesis
- (2013) Yasutomo Nakai et al. INTERNATIONAL JOURNAL OF UROLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
- (2013) G Comito et al. ONCOGENE
- Immunohistochemical Analysis of Inflammatory Cells in Benign and Precancerous Lesions and Carcinoma of the Prostate
- (2013) Tomomi Fujii et al. PATHOBIOLOGY
- Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer
- (2013) Makito Miyake et al. PATHOLOGY RESEARCH AND PRACTICE
- Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell
- (2013) Roberto Benelli et al. PROSTATE
- Metabolomic signatures of aggressive prostate cancer
- (2013) Jonathan E. McDunn et al. PROSTATE
- Neutrophils in innate and adaptive immunity
- (2013) Sébastien Jaillon et al. Seminars in Immunopathology
- Role of Natural Killer and Gamma-Delta T cells in West Nile Virus Infection
- (2013) Tian Wang et al. Viruses-Basel
- Prostate cancer overdiagnosis and overtreatment
- (2013) Laurence Klotz Current Opinion in Endocrinology Diabetes and Obesity
- Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
- (2012) Anna Flammiger et al. APMIS
- The Dark Side of Mast Cell-Targeted Therapy in Prostate Cancer
- (2012) P. Pittoni et al. CANCER RESEARCH
- Molecular Link Mechanisms between Inflammation and Cancer
- (2012) D. B. Vendramini-Costa et al. CURRENT PHARMACEUTICAL DESIGN
- CXCL8, an Underestimated “Bad Guy” in Prostate Cancer
- (2012) Zoran Culig EUROPEAN UROLOGY
- Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer
- (2012) Oleksandr N Kryvenko et al. MODERN PATHOLOGY
- CD4 helper T cells, CD8 cytotoxic T cells and FOXP3+ regulatory T cells with respect to lethal prostate cancer
- (2012) Sabina Davidsson et al. MODERN PATHOLOGY
- Association between SDF1-3′A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases
- (2012) Ferruh K. İşman et al. MOLECULAR BIOLOGY REPORTS
- Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion
- (2012) Qian Wu et al. Molecular Cancer
- The link between benign prostatic hyperplasia and prostate cancer
- (2012) David D. Ørsted et al. Nature Reviews Urology
- Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
- (2012) D. Keizman et al. ONCOLOGIST
- CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
- (2012) Mehrnaz Gharaee-Kermani et al. PLoS One
- CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer
- (2012) Manisha Agarwal et al. PROSTATE
- Growth/differentiation factor-15: prostate cancer suppressor or promoter?
- (2012) P Vaňhara et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Low serum neutrophil count predicts a positive prostate biopsy
- (2012) K Fujita et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation
- (2011) Erin M. Bekes et al. AMERICAN JOURNAL OF PATHOLOGY
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
- (2011) Cosimo De Nunzio et al. EUROPEAN UROLOGY
- Prostate cancer and inflammation: the evidence
- (2011) Karen S Sfanos et al. HISTOPATHOLOGY
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
- (2011) Hexing Yuan et al. JOURNAL OF UROLOGY
- Identification and characterization of a tumor infiltrating CD56+/CD16− NK cell subset with specificity for pancreatic and prostate cancer cell lines
- (2010) Timothy L. Frankel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- Chemokines in cancer related inflammation
- (2010) Paola Allavena et al. EXPERIMENTAL CELL RESEARCH
- Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
- (2010) J. Zhang et al. JNCI-Journal of the National Cancer Institute
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- The chemokine system in cancer biology and therapy
- (2009) Alberto Mantovani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Emerging roles of chemokines in prostate cancer
- (2009) David Vindrieux et al. ENDOCRINE-RELATED CANCER
- Chemokines and chemokine receptors: an overview
- (2009) Raffaella Bonecchi Frontiers in Bioscience-Landmark
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers for Prostate Cancer
- (2008) Danil V. Makarov et al. Annual Review of Medicine
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
- Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer
- (2008) J. Yokokawa et al. CLINICAL CANCER RESEARCH
- Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing
- (2008) K. S. Sfanos et al. CLINICAL CANCER RESEARCH
- Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma
- (2008) Mahmoud-Rezk A. Hussein et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Targeted therapy of cancer: new roles for pathologists—prostate cancer
- (2008) Mark A Rubin MODERN PATHOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
- Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)
- (2008) Stacy Loeb et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More